What Researchers Did
The authors conducted a clinically focused review to critically evaluate evidence for hyperbaric oxygen therapy in managing chronic radiotherapy-related adverse effects.
What They Found
The review found hyperbaric oxygen therapy to be a potential adjunctive treatment for mitigating chronic radiation-induced conditions such as skin fibrosis, bone necrosis, radiation cystitis, and proctitis. Researchers critically evaluated evidence from randomized trials, cohort studies, and real-world data, identifying gaps in knowledge regarding patient selection and optimal treatment protocols.
What This Means for Canadian Patients
Canadian patients experiencing chronic adverse effects from radiotherapy, such as fibrosis or cystitis, may find hyperbaric oxygen therapy to be a beneficial adjunctive treatment. This therapy could potentially improve their quality of life by promoting tissue healing and remodeling in affected areas.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
The review identified limitations in current knowledge, specifically regarding optimal patient selection, treatment protocols, and long-term outcomes for hyperbaric oxygen therapy.